Alla S. Kalugina

Alla S. Kalugina

Auto-generated profile, based on publicly available information

Alla S. Kalugina

Academician I.P. Pavlov First Saint Petersburg State Medical University

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2024 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
OLO. E. Lavrinovich
O. E. Lavrinovich
YTYu. A. Tatischeva
Yu. A. Tatischeva
IBI. V. Berlev
I. V. Berlev
MYM. G. Yakovleva
M. G. Yakovleva
AKA. P. Karitski
A. P. Karitski
AKA. S. Kalugina
A. S. Kalugina
Introduction. An increasing number of patients of reproductive age get cancer and are highly interested in preserving fertility. Survival rates for cancer patients are improving. Methods of reproductive technologies are being improved to preserve the ability to bear children. Rehabilitation aimed to ensure a satisfactory quality of life takes on a new meaning, and with the development of new technologies, the level of possible assistance also changes. Today, rehabilitation measures for cancer patients of reproductive age should undoubtedly include all possible ways to preserve and restore fertility. Aim: preservation of fertility in patients with ovarian tumors. Material and Methods. After ovariectomy, the ovaries were transported to the embryology laboratory, where oocyte-cumulus complexes were extracted and subsequently matured using the OTO-IVM (ovarian tissue oocyte in vitro maturation) method. The resulting mature oocytes (Metaphase II) were cryopreserved by vitrification or, if a partner was available, fertilized by ICSI (intracytoplasmic sperm injection), the embryos were cultured to the blastocyst stage and also cryopreserved by vitrification. Cryopreserved oocytes and embryos can be used by patients after cancer treatment in assisted reproductive technology programs. Results. A total of 218 OCCs were recovered, 29.8 % were degraded oocytes (n=65). The proportion of OCC suitable for ripening was 153 (70.2 %). After 36 or 48 hours, 65 oocytes matured in 13 patients, which amounted to 42.5 % of oocytes without signs of degradation. In 11 patients the OCC was removed from the tumor-affected ovary. 149 oocytes were obtained, of which 50 (33.6 %) were oocytes with signs of degradation. The remaining 99 (66.4 %) of OCCs had satisfactory quality; after maturation, the Metaphase II stage reached in 49 (49.5 %) of oocytes. As a result, biological material was cryopreserved in 13 of 15 patients: 5 embryos and 60 oocytes.

1 January 2015 in Russian Journal of Human Reproduction
Verified
Journal Article
Open access
VGV. V. Gabaraeva
V. V. Gabaraeva
АКА. С. Калугина
А. С. Калугина
Издательство Медиа Сфера - 25 медицинских журналов общим тиражом около 500 000 экземпляров в год, представлены в международных базах данных Scopus, Medline, и Google Scolar, включены в перечень изданий ВАК, представлены в РИНЦ

28 September 2020 in Journal of obstetrics and women's diseases
Verified
Journal Article
Open access
PDF file
SPSvetlana S. Paskar
Svetlana S. Paskar
AKAlla S. Kalugina
Alla S. Kalugina
ATAnna G. Tkachuk
Anna G. Tkachuk
The expansion of indications for assisted reproductive technology has led to significant implications for assisted reproductive technology (ART) programs worldwide. More than 7 million children in the world were born using ART. Modern clinical practice in the field of reproductive sciences is aimed not only at increasing the effectiveness, but also at the safety of treatment. ART, like any other type of therapy, may be combined with negative side effects. Both the correct prediction of the risks associated with treatment and a personalized approach ensure the absolute safety of infertility treatment using in vitro fertilization. In this regard, over the past decade, a number of new research approaches have been noted that use ART methods integrated into clinical practice: cycle segmentation with subsequent embryo transfer and the elective transfer of one embryo. New approaches provide a control in relation to ovarian stimulation and a reduction in the number of transferred embryos, which helps to minimize primarily adverse perinatal outcomes. Predicting the risks and outcomes of treatment using mathematical modeling is the application of good clinical practice.

15 January 2022 in Journal of obstetrics and women's diseases
Verified
Journal Article
Closed access
PDF file
VBVitaly F. Bezhenar
Vitaly F. Bezhenar
VLViktor A. Linde
Viktor A. Linde
BAByuzand V. Arakelyan
Byuzand V. Arakelyan
AKAlla S. Kalugina
Alla S. Kalugina
YVYuri V. Vasilyev
Yuri V. Vasilyev
ВВВасильев Юрий Валерианович
Васильев Юрий Валерианович
This literature review is based on resources from the following databases: CyberLeninka, PubMed, MedArt, and the Central Scientific Medical Library (I.M. Sechenov First Moscow State Medical University, Moscow, Russia). Adenomyosis is a common non-infectious uterine pathology associated with the risk of infertility and obstetric problems. The local inflammation that develops in adenomyosis reduces the probability of blastocyst implantation and creates an unfavorable environment for the development of the embryo. Adenomyosis reduces the effectiveness of assisted reproductive technology. During the pregnancy in adenomyosis, the risk of incomplete and prolonged pregnancy increases at almost all stages. Besides, the risk of massive hemorrhage increases during pregnancy, childbirth and the early postpartum period. The presented review helps to assess the pathogenetic mechanisms underlying the negative effect of adenomyosis on womens fertility based on data obtained over the past ten years.

27 May 2024 in Journal of obstetrics and women's diseases
Verified
Journal Article
Open access
PDF file
YDYuliya A. Dumanskaya
Yuliya A. Dumanskaya
AKAlla S. Kalugina
Alla S. Kalugina
A poor ovarian response to ovarian stimulation is a factor that significantly reduces the effectiveness of in vitro fertilization programs. Managing these patients remains an unresolved issue in assisted reproductive technology programs. The difficulties are largely determined by the heterogeneity of groups of patients with a poor ovarian response and the need for a personalized approach to ovarian stimulation. This review covers the data from the global literature on the management tactics of patients with a poor ovarian response according to the POSEIDON classification, with the aim of increasing the quantity and quality of retrieved oocytes and clinical pregnancy rates.